Clinic
Edgerton Hospital and Health Services INC.
Edgerton Hospital and Health Services INC. was paid $3.86M by Medicaid between Jan 2018 and Dec 2024, across 61 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 29% of everything it billed.
33Billing provider infoEDGERTON HOSPITAL AND HEALTH SERVICES INC.
EDGERTON, WI 53534
EDGERTON, WI 53534
33aNPI1154350049assigned 07/02/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$3.86M
24GClaims30,976
24DCodes billed61
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Wisconsin
Rank by total paid#9 of 40
Median peer was paid$333K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,780 | $293K | |
| 2019 | 4,049 | $462K | |
| 2020 | 3,685 | $500K | |
| 2021 | 5,655 | $533K | |
| 2022 | 4,989 | $515K | |
| 2023 | 5,544 | $740K | |
| 2024incomplete | 4,274 | $816K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 29% | 3,987 | 3,385 | $1.12M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 15% | 1,352 | 1,163 | $580K |
| 41899 | Unlisted procedure, dentoalveolar structures | 14% | 207 | 162 | $527K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 1,353 | 1,014 | $425K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.4% | 1,329 | 1,043 | $323K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.0% | 619 | 503 | $195K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4.7% | 602 | 530 | $181K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.9% | 185 | 145 | $150K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.1% | 429 | 343 | $118K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.4% | 299 | 145 | $56K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,062 | 936 | $38K |
| 80053 | Comprehensive metabolic panel | <1% | 2,612 | 2,134 | $30K |
49 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 316 | $24K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 90 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,476 | $12K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 299 | $11K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 204 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 688 | $10K |
| 87081 | <1% | 666 | $5K | |
| 81001 | <1% | 1,193 | $4K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 41 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 920 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,189 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 411 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 359 | $2K |
| 84484 | <1% | 230 | $1K | |
| 81025 | <1% | 216 | $1K | |
| 80061 | Lipid panel | <1% | 103 | $1K |
| 83605 | <1% | 102 | $848.49 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 42 | $764.75 |
| 71045 | Radiologic examination, chest; single view | <1% | 121 | $763.88 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 311 | $678.63 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 14 | $624.44 |
| 83690 | <1% | 117 | $601.88 | |
| 0012A | <1% | 14 | $581.11 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 77 | $576.58 |
| 82607 | <1% | 58 | $560.88 | |
| 0011A | <1% | 16 | $528.88 | |
| 85027 | <1% | 124 | $510.56 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 39 | $468.72 |
| 85610 | <1% | 113 | $374.55 | |
| 82746 | <1% | 36 | $364.56 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 80 | $354.04 |
| 0031A | <1% | 20 | $339.48 | |
| 80050 | General health panel | <1% | 15 | $267.79 |
| 84439 | <1% | 35 | $223.68 | |
| 83735 | <1% | 33 | $131.48 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 435 | $91.67 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 429 | $80.24 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 16 | $66.72 |
| 91301 | <1% | 16 | $35.50 | |
| 85007 | <1% | 13 | $28.08 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,015 | $17.12 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 434 | $12.07 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 235 | $8.92 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 752 | $6.72 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 188 | $2.18 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 141 | $1.45 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 32 | $0.10 |
| J2704 | Injection, propofol, 10 mg | 0% | 400 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 66 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAUGSBURGER, MARC (PRESIDENT AND CEO)